Research Collaboration and Licensing
Kyowa Hakko Kirin’s business vision is fulfilled through diligent and continuous efforts to bring innovative pharmaceuticals to patients, utilizing our R&D expertise and knowledge.
We recognize that accessing and pursuing external opportunities for our R&D activities is an indispensable and essential aspect of our strategy to establish a solid pipeline of products.
We are actively seeking opportunities within the following focused therapeutic areas.
Should you have an opportunity within these areas that you would like to present to us, we would invite you to contact us using the link below. We would be delighted to explore how we can work together to maximize the value of any such opportunity.
We strive to create innovative value in pharmaceuticals by positioning oncology, nephrology, immunology/allergy and central nervous system as our focused therapeutic areas.
External Research and Collaboration
We think “Open Innovation” is essential for drug discovery and actively seek for research collaboration opportunities especially on novel target finding, discovery-to-preclinical stage drug candidates, and innovative technologies for accelerating drug development. We are open and flexible to strategic collaborations or partnerships with pharmaceuticals, biotech, and academia partners.
Licensing and Partnering
We have established licensing and partnering with excellent companies.
- Kyowa Hakko Kirin's Partners (780KB)